Save 20% on Press Releases and More with NNW Prime! Click to View Details
MondayDec 08, 2025 9:10 am

NetworkNewsBreaks – Canamera Energy Metals Corp. (CSE: EMET) Enters Option Agreement to Acquire Up to 90 Percent of Great Divide Basin Uranium Project

This article has been disseminated on behalf of Canamera Energy Metals Corp. and may include paid advertising. Canamera Energy Metals (CSE: EMET) announced it has entered an option agreement to acquire up to a 90 percent interest in the Great Divide Basin uranium project in Wyoming’s Fremont and Sweetwater counties. The 2,080-acre property sits within a prolific uranium-producing region and marks Canamera’s entry into U.S. uranium exploration. CEO Brad Brodeur said the project provides a strong foundation for systematic exploration. The staged earn-in includes share issuances, cash payments, and exploration spending across three option phases, ultimately leading to a joint…

Continue Reading

FridayDec 05, 2025 12:46 pm

NetworkNewsBreaks – Carrier Connect Data Solutions Inc. (TSX.V: CCDS) (OTCQB: CCDSF) (WKN: A40XB1) Completes Acquisition of PureColo 

This article has been disseminated on behalf of Carrier Connect Data Solutions Inc.  and may include paid advertising. Carrier Connect Data Solutions (TSX.V: CCDS) (OTCQB: CCDSF) (WKN: A40XB1) has completed its acquisition of PureColo, an established Ottawa-based provider of carrier-neutral data centers offering colocation and server hosting solutions. The Company issued 4,606,704 consideration shares and will pay about $2,326,000 over nine months to PureColo securityholders, with the shares released from escrow in thirds at four, eight and twelve months after Dec. 4, 2025. CEO Mark Binns said the addition of PureColo’s two Ottawa data centers expands scale, revenue and growth…

Continue Reading

FridayDec 05, 2025 10:22 am

NetworkNewsBreaks – Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) (FSE: T23) Outlines Phase 1 Exploration Plan for Pinard REE Project 

This article has been disseminated on behalf of Powermax Minerals Inc.  and may include paid advertising.  Powermax Minerals (CSE: PMAX) (OTCQB: PWMXF) (FSE: T23) announces its Phase 1 exploration program for the optioned Pinard Project in northern Ontario. The program will integrate historical data with new fieldwork to refine target generation across the 255 contiguous claims covering 5178 ha, located about 70 km north-northeast of Kapuskasing with access via all-weather roads. The Pinard Intrusive Complex, an alkalic to peralkalic body comparable to other alkaline systems in the southern Archean Superior Province, shares regional characteristics with the nearby Clay-Howells Complex, which…

Continue Reading

FridayDec 05, 2025 10:09 am

NetworkNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Featured in BioMedWire Editorial on Rare Disease Therapies 

Soligenix (NASDAQ: SNGX), announces its inclusion in a BioMedWire editorial examining the urgent rise of chronic and rare diseases in aging populations. With more than 30 million Americans living with rare disorders that often lack FDA-approved treatments, demand for novel therapies continues to grow. Soligenix is advancing late-stage programs including HyBryte(TM) for cutaneous T-cell lymphoma, now in its final confirmatory trial, positioning the Company at the intersection of scientific innovation and evolving national health-policy priorities focused on chronic and rare conditions. To view the full press release, visit https://nnw.fm/YjM5V About Soligenix Inc. Soligenix is a late-stage biopharmaceutical company focused on…

Continue Reading

FridayDec 05, 2025 9:10 am

NetworkNewsBreaks – Belite Bio, Inc (NASDAQ: BLTE) Prices $350M Underwritten Public Offering of ADSs

Belite Bio (NASDAQ: BLTE) has priced an underwritten public offering of 2,272,727 American Depositary Shares at $154.00 per ADS, with a 30-day option for underwriters to purchase up to 340,909 additional ADSs. Gross proceeds are expected to total about $350 million before fees. The Company plans to use net proceeds for commercialization preparation, pipeline development, and general corporate purposes. Morgan Stanley & Co. LLC, Leerink Partners, BofA Securities and Cantor are serving as joint active book-running managers, with H.C. Wainwright & Co. as lead manager and Maxim Group LLC and Titan Partners Group as co-managers. To view the full press…

Continue Reading

FridayDec 05, 2025 9:00 am

NetworkNewsBreaks – Lelantos Holdings, Inc. (OTCID: LNTO) Engages PCAOB-Approved Auditor to Support Planned OTCQB Uplist

Lelantos Holdings (OTCID: LNTO) has engaged Aloba, Awomolo & Partners, a PCAOB-approved auditing firm, to complete its financial audits as the Company prepares an application to uplist its common stock to the OTCQB Venture Market. AAP will perform independent audits under PCAOB standards to support enhanced transparency, stronger internal controls, and alignment with OTCQB reporting requirements. Founded in 1981, the firm provides audit, tax, and financial advisory services with expertise in IFRS and PCAOB-standard external audits. Lelantos views the engagement as a key step toward improving liquidity, expanding its investor base, and increasing capital markets visibility. To view the full…

Continue Reading

ThursdayDec 04, 2025 1:09 pm

NetworkNewsBreaks – Parler Technologies, Inc. Launches Regulation D 506(c) Offering Ahead of Planned 2026–2027 Uplisting

Parler Technologies has initiated a Regulation D, Rule 506(c) private placement to raise up to $50 million, with the option to increase to $100 million, ahead of a planned Nasdaq or NYSE public offering targeted for late 2026 or early 2027. Managed by Digital Offering, the raise allows accredited investors to participate in Parler’s rebuilt, fully sovereign technology ecosystem, which includes Triton Cloud, Edgecast CDN, PlayTV, Kyvo, Cartix, and ParlerNews operating on an integrated blockchain protocol layer. The company says its independent infrastructure significantly reduces operating costs and enhances creator earnings while enabling a unified creator-commerce platform designed to support…

Continue Reading

ThursdayDec 04, 2025 11:45 am

NetworkNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) identifies Biomarker Signature Predicting Sensitivity to IV Sapu003

Oncotelic Therapeutics (OTCQB: OTLC), reports that its 45% owned joint venture, Sapu Nano, has identified a High-RICTOR/Low-RPTOR molecular signature that predicts tumor sensitivity to Sapu003, the company’s intravenous Deciparticle(TM) formulation of everolimus. The biomarker framework, to be presented at the 2025 San Antonio Breast Cancer Symposium, is based on analysis of more than 9,000 tumor samples across 20 cancer types and represents the first prospective selection strategy for IV everolimus. Data show that mTORC2-dominant tumors — including HR+/HER2- breast, lung adenocarcinoma, gastric, renal, ovarian, AML and T-cell malignancies — exhibit heightened mTOR dependency and predicted sensitivity to Sapu003, which overcomes…

Continue Reading

ThursdayDec 04, 2025 11:34 am

NetworkNewsBreaks – MAX Power Mining (CSE: MAXX) (OTC: MAXXF) (FRANKFURT: 89N) Appoints Neil McMillan as Chairman of the Board 

This article has been disseminated on behalf of MAX Power Mining and may include paid advertising. MAX Power Mining (CSE: MAXX) (OTC: MAXXF) (FRANKFURT: 89N) has appointed longtime Saskatchewan resource and capital markets leader Neil McMillan as Chairman of the Board as the Company accelerates its Natural Hydrogen initiatives across the province. McMillan, former Chairman of Cameco and past President and CEO of Claude Resources, brings decades of financial, operational, and policy expertise at a pivotal stage for MAX Power, which has advanced early drilling success and a large permitted land position. Leadership says his expanded role strengthens governance and…

Continue Reading

ThursdayDec 04, 2025 9:59 am

NetworkNewsBreaks – VolitionRx (NYSE American: VNRX) Nu.Q NETs Assay Selected for France’s National Sepsis Detection Initiative

VolitionRx Ltd. (NYSE American: VNRX) (“Volition”), a multi-national epigenetics company, announced that its Nu.Q® NETs H3.1 assay has been chosen as the sole biomarker for “DETECSEPS,” a French government-funded evaluation of early sepsis detection under the France 2030 plan. The program, led by the IHU SEPSIS and supported by a €6.3 million (~$7.3 million) grant, aims to transform emergency care for patients with infection and risk of sepsis progression. Professor Djillali Annane, Intensive Care Department, IHU SEPSIS, Raymond Poincaré Hospital (AP-HP) and Scientific Director of DETECSEPS, noted that combining Volition’s Nu.Q® H3.1 biomarker with a clinical score (NEWS2) could improve…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000